Cargando…

Challenges with PCSK9 Inhibitors Use in Asia Given Real-World Data Implications

Detalles Bibliográficos
Autor principal: Uno-Eder, Kiyoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499451/
https://www.ncbi.nlm.nih.gov/pubmed/36948635
http://dx.doi.org/10.5551/jat.ED230
_version_ 1785105712156770304
author Uno-Eder, Kiyoko
author_facet Uno-Eder, Kiyoko
author_sort Uno-Eder, Kiyoko
collection PubMed
description
format Online
Article
Text
id pubmed-10499451
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-104994512023-09-14 Challenges with PCSK9 Inhibitors Use in Asia Given Real-World Data Implications Uno-Eder, Kiyoko J Atheroscler Thromb Editorial Japan Atherosclerosis Society 2023-09-01 2023-03-22 /pmc/articles/PMC10499451/ /pubmed/36948635 http://dx.doi.org/10.5551/jat.ED230 Text en 2023 Japan Atherosclerosis Society https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Editorial
Uno-Eder, Kiyoko
Challenges with PCSK9 Inhibitors Use in Asia Given Real-World Data Implications
title Challenges with PCSK9 Inhibitors Use in Asia Given Real-World Data Implications
title_full Challenges with PCSK9 Inhibitors Use in Asia Given Real-World Data Implications
title_fullStr Challenges with PCSK9 Inhibitors Use in Asia Given Real-World Data Implications
title_full_unstemmed Challenges with PCSK9 Inhibitors Use in Asia Given Real-World Data Implications
title_short Challenges with PCSK9 Inhibitors Use in Asia Given Real-World Data Implications
title_sort challenges with pcsk9 inhibitors use in asia given real-world data implications
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499451/
https://www.ncbi.nlm.nih.gov/pubmed/36948635
http://dx.doi.org/10.5551/jat.ED230
work_keys_str_mv AT unoederkiyoko challengeswithpcsk9inhibitorsuseinasiagivenrealworlddataimplications